pharma · Renal Impairment · Urinary Tract Infection · SPRO
Spero Therapeutics
Spero Therapeutics patent portfolio — 16 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 675 Massachusetts Ave, 14th Floor, Cambridge, MA 02139, US
- Founded
- 2013
- Employees
- 45
- Programs
- 21
- Drugs
- 9
- Patents
- 16
Spero Therapeutics patents
16 pharmaceutical patents indexed for Spero Therapeutics. 0 expire within 24 months.
Spero Therapeutics has 16 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12428395
Heterocyclic compounds as kinase inhibitor and uses thereof
granted -
US 12291548
Compounds, compositions, and methods for the treatment of disease
granted -
US 12226403
Tebipenem pivoxil immediate and modified release oral dosage forms
granted -
US 12146004
Polymyxin compounds and uses thereof
granted -
US 12098155
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 12048691
High dosage tebipenem pivoxil tablet formulation
granted -
US 11718621
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 11459357
Polymyxin compounds
granted -
US 11180444
Polyimino ketoaldehydes
granted -
US 11033569
Compounds,Compositions, and methods for the treatment of disease
granted -
US 10889587
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 10793482
Compounds and compositions for delivery of nutrients and micronutrients to plants
granted -
US 9937192
Combination therapy to treat mycobacterium diseases
granted -
US 9604976
Antibacterial compounds
granted -
US 9572809
Combination therapy to treat Mycobacterium diseases
granted -
US 6593394
Bioactive and osteoporotic bone cement
expired
Frequently asked questions
How many patents does Spero Therapeutics have?
16 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Spero Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.